The nurse auscultates a S4 heart sound during the morning assessment of a client. Which additional assessment data would correlate with this finding?

A) Depending on the client's age, the findings may be normal: While changes in hair growth and nail texture can occur with aging, the specific combination of hair loss on the legs and thick toenails in a client with peripheral vascular disease is indicative of underlying circulatory issues rather than simply a normal aging process.

B) A blood clot may be forming and the client needs immediate intervention: While peripheral vascular disease does increase the risk of blood clots, the presence of no hair on the legs and thick toenails is more directly related to chronic insufficient blood flow rather than an acute clotting situation requiring immediate intervention.

C) Decreased oxygen to the tissues causes changes in hair growth and nail texture: This statement accurately describes the physiological changes occurring in peripheral vascular disease. Reduced blood flow and oxygen delivery to the lower extremities result in hair loss and thickened nails, as hair follicles and nail growth depend on adequate perfusion.

D) Decreased hair is most likely a hereditary condition and nail changes are related to fungus: While hereditary factors can influence hair loss and fungal infections can affect nails, in the context of peripheral vascular disease, the findings are primarily due to inadequate blood supply rather than hereditary issues or fungal infections.

A. Remove the patch if a headache develops: While headaches can be a side effect of clonidine, removing the patch is not the recommended immediate action without further assessment. The patient should be advised to consult with their healthcare provider if they experience significant side effects.

B. Monitor weight on a daily basis: While weight monitoring is important for some medications, it is not a specific recommendation for clonidine. Patients should be informed to monitor for signs of fluid retention or significant weight changes, but daily weight monitoring is not typically required.

C. Place the patch on the anterior chest: The clonidine patch should be placed on a hairless area of skin, typically on the upper arm or chest, but the anterior chest is not specific enough. Patients should be instructed to follow the manufacturer's guidelines for proper placement.

D. Remove the patch as directed and inspect the skin: This is the best discharge instruction. Patients should be informed to remove the patch according to the prescribed schedule and to inspect the skin for any irritation or allergic reactions. Regular skin checks are important to prevent any adverse reactions from prolonged patch use.